Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04443348
Title Pre-op Pembro + Radiation Therapy in Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alice Ho
Indications

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

Therapies

Pembrolizumab

Cyclophosphamide + Doxorubicin + Paclitaxel + Pembrolizumab

Carboplatin + Cyclophosphamide + Doxorubicin + Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.